DPSC-Derived Extracellular Vesicles Promote Rat Jawbone Regeneration
Journal of Dental Research · 2023-03 · 102 (3) · 313-321
DOI: 10.1177/00220345221133716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dental Research, online erschienen am 08.11.2022. Verfasst von A E Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery and Pharmacology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Osteogenesis, Extracellular Vesicles. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Repair and functional reconstruction of large jawbone defects remain one of the challenges in the field of head and neck surgery. The recent progress in tissue engineering technologies and stem cell biology has significantly promoted the development of regenerative reconstruction of jawbone defects. The multiple trophic activities of extracellular vesicles (EVs) produced by mesenchymal stem cells (MSCs) may play a critical role in their therapeutic effects. Accumulating evidence has shown the promise of dental pulp stem cells (DPSCs) in bone regeneration, but less is known about the regenerative effects of DPSC-EVs on jawbone defects. The purpose of this study is to explore the osteogenic effects of DPSC-EVs on jawbone marrow–derived MSCs (JB-MSCs) in vitro and their osteoinductive effects in a mandibular bone defect model in rats. Our results showed that JB-MSCs could efficiently uptake DPSC-EVs, which in turn significantly promoted the expression of osteogenic genes, such as runt-related transcription factor 2 ( RUNX2), alkaline phosphatase ( ALP), and osteocalcin ( OCN), as well as the osteogenic differentiation capability of JB-MSCs. Meanwhile, we found that the pro-osteogenic effect in vitro induced by DPSC-EVs was comparable to that induced by BMP-2 (bone morphogenetic protein 2), currently the only Food and Drug Administration–approved osteoinductive growth factor. In vivo, animals that were locally treated with DPSC-EVs laden with a commercially available collagen membrane exhibited a relatively fast wound closure and increased new bone density at the mandible defects. Our results provide evidence for the osteogenic and osteoinductive effects of DPSC-EVs on jawbone regeneration. Due to the accessibility, rapid proliferation, and osteogenic propensity of DPSCs, DPSC-EVs may represent a safe cell-free therapeutic approach for craniofacial bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery and Pharmacology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Oral and Maxillofacial Surgery, NYU Langone Hospitals, New York, NY, USA.
- Department of Oral and Maxillofacial Surgery, Perelman Center for Advanced Medicine, Penn Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Zitieren
APA
Lee, A. E., Choi, J. G., Shi, S. H., He, P., Zhang, Q. Z., & Le, A. D. (2023). DPSC-Derived Extracellular Vesicles Promote Rat Jawbone Regeneration. Journal of Dental Research, 102(3), 313-321. https://doi.org/10.1177/00220345221133716
Vancouver
Lee AE, Choi JG, Shi SH, He P, Zhang QZ, Le AD. DPSC-Derived Extracellular Vesicles Promote Rat Jawbone Regeneration. Journal of Dental Research. 2023;102(3):313-321. doi:10.1177/00220345221133716
BibTeX
@article{Lee2023,
author = {Lee, A E and Choi, J G and Shi, S H and He, P and Zhang, Q Z and Le, A D},
title = {DPSC-Derived Extracellular Vesicles Promote Rat Jawbone Regeneration},
journal = {Journal of Dental Research},
year = {2023},
volume = {102},
number = {3},
pages = {313--321},
doi = {10.1177/00220345221133716}
}
EUVIMED